Health Canada Approves Zepbound for OSA in Adults With Obesity
Tirzepatide injection becomes the first medication authorized in Canada for moderate to severe OSA, demonstrating significant reductions in breathing disruptions in clinical trials.
Category: Pharmaceuticals
Pharmaceuticals
Latest
Pharmaceuticals
Latest
How to Afford CPAP + GLP-1 Polytherapy
What can sleep physicians do when obstructive sleep apnea patients can't afford every recommended therapy?
Pharmaceuticals
Latest
Steady-State Pharmacokinetics for Sublingual Tablet That Targets Nonrestorative Sleep Linked to Fibromyalgia
The peer-reviewed study highlights how the sublingual cyclobenzaprine formulation targets nonrestorative sleep and bypasses first-pass metabolism.
Prescription Drugs
Latest
Why an Efficacious Drug Therapy for Narcolepsy Is Underused
Low prescribing rates persist even as evidence supports benefit, pointing to missed conversations, unclear expectations, and fragile early treatment periods.
Over-the-Counter Treatments
Latest
Saline Nasal Spray Shows Efficacy in Treating Pediatric Sleep-Disordered Breathing
A new Australian study finds that a simple saline nasal spray can resolve symptoms of obstructive sleep-disordered breathing in children, potentially reducing the need for surgery and specialist care.
Emerging Compounds
Latest
Eisai Begins Enrolling Phase 2 Study for Narcolepsy Treatment E2086
The dose escalation study will evaluate the efficacy, safety, and tolerability of a novel selective orexin-2 receptor agonist in adults with narcolepsy type 1 and type 2.